Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: BioVaxys Technology Corp

Announces it has been invited to and joined The Rapid Response Partnership Vehicle (RRPV), a consortium ...

BIOV.CN : 0.0700 (unch)
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
Stocks in play: BioVaxys Technology Corp

Announces studies showing that its novel immune educating delivery platform, DPXâ„¢, recruits and activates ...

BIOV.CN : 0.0700 (unch)
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
Stocks in play: BioVaxys Technology Corp

Announces that Chief Executive Officer James Passin has been invited to present live at the Emerging ...

BIOV.CN : 0.0700 (unch)
BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
BIOVAXYS PROVIDES PRIVATE PLACEMENT UPDATES

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that, further to its news releases regarding its previously...

BIOV.CN : 0.0700 (unch)
Stocks in play: BioVaxys Technology Corp

Announces it has engaged Rajkannan Rajagopalan, PhD, as Advisor for development and production of the ...

BIOV.CN : 0.0700 (unch)
BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan, PhD,...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed the fifth tranche (the "Fifth...

BIOV.CN : 0.0700 (unch)

Barchart Exclusives

Is This Fintech Stock a Buy Before Its Q1 Earnings Release?
Intuit is a high-quality fintech stock with growing potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar